CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Income Charts

2 years of history · ending 2025-12-27 · SEC EDGAR

Source:10-K · 10-Q

Revenue, Gross Profit, Operating Income & Net Income

Margin (%)

Operating Expenses

Income Breakdown

Revenue
$4.02B
Cost of Revenue
SG&A
$743M
D&A
$403M
Operating Income
$25M
EBITDA
$428M
Interest Expense
$107M
Interest Income
$5M
Other Income/Expense
$-23M
Pretax Income
$-100M
Tax Provision
$43M
Net Income
$-144M
Operating Margin
0.6%
Net Margin
-3.6%
Effective Tax Rate
-42.9%
Deferred Tax Assets
$278M
Deferred Tax Liabilities
$95M
DTA Valuation Allowance
$323M
NOL Carryforwards
ETR (Continuing Operations)
-42.9%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-1.2%
ETR Foreign Differential (pp)
11.1%
Operating Lease Cost
$71M
Pension Net Periodic Cost
$3M
Revenue YoY Variation
-0.9%
Income YoY Variation
-88.9%
No segment data available for this ticker. Source: quarterchart.com.